T. Rowe Price Investment Management, Inc.

Position in TXG — 10x Genomics, Inc.

CIK 1897612 BALTIMORE, MD

Position in TXG

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$48,575,016

+$21,413,737 QoQ

Shares Held

1,266,954

-1.0% QoQ

Ownership

0.972%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

T. Rowe Price Investment Management, Inc. holds $703,036,151 across 14 Medical Devices names. TXG ranks #6 (6.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PODD	Insulet Corp	1,512,160	$230,226,360
2	NEOG	Neogen Corp	9,333,261	$83,906,016
3	HAE	Haemonetics Corp	1,101,371	$82,602,825
4	PRCT	PROCEPT BioRobotics Corp	3,265,704	$73,739,596
5	ALMR	Alamar Biosciences, Inc.	2,202,597	$59,668,352
6	TXG	10x Genomics, Inc. This page	1,266,954	$48,575,016
7	QDEL	QuidelOrtho Corp	1,743,563	$30,547,223
8	IRMD	Iradimed Corp	318,680	$30,453,060

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$48,575,016	1,266,954	-1.0%	Shares	Sole	2026-08-14
2026-03-31	$27,161,279	1,279,382	-0.0%	Shares	Sole	2026-05-15
2025-12-31	$20,868,693	1,279,503	-4.7%	Shares	Sole	2026-02-19
2025-09-30	$15,692,924	1,342,423	+37.3%	Shares	Sole	2025-11-14
2025-06-30	$11,321,592	977,685	-54.8%	Shares	Sole	2025-08-14
2024-09-30	$48,812,879	2,161,775	-0.1%	Shares	Sole	2024-11-14
2024-06-30	$42,069,941	2,162,979	-1.9%	Shares	Sole	2024-08-14
2024-03-31	$82,732,257	2,204,430	+93.2%	Shares	Sole	2024-05-15
2023-12-31	$63,852,822	1,141,044	+14.5%	Shares	Sole	2024-02-14
2023-09-30	$41,112,431	996,665	0.0%	Shares	Sole	2023-11-14
2023-06-30	$55,653,773	996,665	-2.9%	Shares	Sole	2023-08-14
2023-03-31	$57,238,364	1,025,961	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.